Cytomegalovirus infection in a recipient of solitary allogeneic islets [4]

American Journal of Transplantation

Volumn 6, Issue 5 I, 2006, Pages 1089-1090

  Cure, P ^a   Pileggi, A ^a,b   Faradji, R N ^a,b   Baidal, D A ^a   Froud, T ^a,b   Selvaggi, G ^a,b   Ricordi, C ^a,b   Alejandro, R ^a,b  

^a Diabetes Research Institute   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; HYPERIMMUNE GLOBULIN; INSULIN; MESALAZINE; RAPAMYCIN; TACROLIMUS;

ALLOGRAFT; CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SEROCONVERSION; ALLOTRANSPLANTATION; COMMUNICABLE DISEASE; CYTOMEGALIC INCLUSION BODY DISEASE; DISEASE TRANSMISSION; POSTOPERATIVE COMPLICATION; TIME; VIROLOGY;

COMMUNITY-ACQUIRED INFECTIONS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33745288557     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01319.x     Document Type: Letter

References (6)

1. Froud T, Ricordi C, Baidal DA et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 2037-2046.
2. Hafiz MM, Poggioli R, Caulfield A et al. Cytomegalovirus prevalence and transmission after islet allograft transplant in patients with type 1 diabetes mellitus. Am J Transplant 2004; 4: 1697-1702.
3. Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060-2069.
4. Barshes NR, Lee TC, Brunicardi FC et al. Lack of cytomegalovirus transmission after pancreatic islet transplantation. Cell Transplant 2004; 13: 833-838.
5. Warnock GL, Kneteman NM, Ryan EA, Rabinovitch A, Rajotte RV. Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 89-95.
6. Eckhard M, Martin I, Eich T et al. Incidence of cytomegalovirus infections after immunosuppression induction in clinical islet transplantation and impact on graft function. Transplant Proc 2002; 34: 1922-1924.